CSIMarket


Organicell Regenerative Medicine Inc.  (BPSR)
Other Ticker:  
 

Organicell Regenerative Medicine Inc.

BPSR's Fundamental analysis








Looking into Organicell Regenerative Medicine growth rates, revenue grew by 25.24 % in III. Quarter 2022 from the same quarter a year ago. Ranking at No. 1207

Special Transportation Services industry recorded growth of revenues by 18.46 %



More on BPSR's Growth


Organicell Regenerative Medicine
realized net loss in trailing twelve months.

Company
PE TTM   
Industry
54.15
PE TTM    
Special Transportation Services industry's Price to Sales ratio is at 2.48.


More on BPSR's Valuation
 
 Total Debt (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 68.36
 Tangible Book Value (Per Share $)

Organicell Regenerative Medicine
realized net loss in trailing twelve months.

Company
PE TTM   
Industry
54.15
PE TTM    
Special Transportation Services industry's Price to Sales ratio is at 2.48.